AGA Rangemaster: N+1 Singer ups target price from 175p to 192p and maintains a buy recommendation.
Aggreko: JP Morgan lowers target price from 1542p to 1536p and maintains a neutral rating. Goldman Sachs increases target price from 1876p to 1950p and keeps a buy recommendation. Numis upgrades to reduce with a target price of 1234p.
Atkins (WS): JP Morgan raises target price from 1466p to 1619p and retains its overweight rating.
Aureus Mining: RBC Capital lowers target price from 70p to 60p and reiterates its outperform rating.
Aviva: JP Morgan raises target price from 491p to 528p and keeps an overweight rating. Barclays raises target price from 380p to 415p, but stays with its underweight rating.
Avocet Mining: Investec lowers target price from 12.1p to 11.8p and reiterates a hold recommendation.
Balfour Beatty: Investec places both its target price (prev.: 170p) and its sell recommendation under review.
Betfair Group: JP Morgan increases target price from 990p to 1100p and keeps a neutral rating. Barcalys takes target price from 1120p to 1245.6p maintaining an overweight rating.
BP: UBS moves target price from 500p to 515p and retains a neutral rating.
Cranswick: Panmure Gordon ups target price from 1300p to 1330p and keeps a hold recommendation.
Faroe Petroleum: Credit Suisse shifts target price from 119p to 125p, while staying with its underperform rating.
Fresnillo: Citi raises target price from 781p to 847p, but still recommends selling.
Goals Soccer Centres: Panmure Gordon downgrades from buy to hold with a target price of 213p.
HSBC Holdings: Goldman Sachs reduces target price from 900p to 740p and downgrades from strong buy to buy.
Hunting: Deutsche Bank raises target price from 900p to 950p and maintains a buy recommendation. Barclays cuts target price from 1100p to 1050p, while leaving its overweight rating unaltered.
Imagination Technologies Group: RBC Capital lowers target price from 130p to 120p and retains an underperform rating. JP Morgan reduces target price from 425p to 210p, while leaving its overweight rating unaltered. Berenberg cuts target price from 210p to 160p reiterating its sell recommendation. Credit Suisse cuts target price from 175p to 130p and stays with its underperform rating.
IMI: JP Morgan lowers target price from 1670p to 1655p and keeps an overweight rating. Barclays cuts target price from 1490p to 1450p and leaves its equal-weight rating unchanged.
Intu Properties: Goldman Sachs lowers target price to 300p and downgrades to sell.
Jardine Lloyd Thompson: Investec moves target price from 1130p to 1170p and retains an add rating.
Johnson Service Group: Investec ups target price from 52p to 70p and maintains its buy recommendation.
Kazakhmys: Jefferies takes target price from 250p to 310p and stays with its hold recommendation.
London Mining: JP Morgan lowers target price from 170p to 160p and retains an overweight rating.
National Express: RBC Capital increases target price from 290p to 340p and retains its outperform rating.
Novae Group: Westhouse Securities raises target price from 580p to 640p and upgrades from neutral to buy.
Rightmove: Westhouse Securities raises target price from 2570p to 2700p and keeps a neutral rating.
Royal Dutch Shell: JP Morgan ups target price from 2250p to 2270p maintaining a neutral rating.
Royal Mail: JP Morgan takes target price from 700p to 765p and keeps an overweight rating.
Schroders: JP Morgan increases target price from 2802p to 2946p and reiterates an overweight rating. Barclays ups target price from 3010p to 3075p maintaining its overweight rating.
Spirax-Sarco Engineering: Investec places both its target price (prev.: 3425p) and its buy recommendation under review. Numis downgrades to hold with a target price of 3200p.
Standard Chartered: Deutsche Bank reduces target price from 1410p to 1360p, while leaving its hold recommendation unchanged.
Stratex International: Northland lowers target price from 12.8p to 10.9p and keeps a buy recommendation.
Taylor Wimpey: Barclays shifts target price from 156.5p to 160.1p and maintains an overweight rating.
Verona Pharma: N+1 Singer initiates with a target price of 5.1p and a buy recommendation.